Review



web-based sequencing assay design tool design studio  (Illumina Inc)


Bioz Verified Symbol Illumina Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Illumina Inc web-based sequencing assay design tool design studio
    Targets for next generation <t> sequencing </t> assay, chromosomal location, length of the amplified regions and number of amplicons per target.
    Web Based Sequencing Assay Design Tool Design Studio, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/web-based+sequencing+assay+design+tool+design+studio/illumina+s+assay+design+tool/pmc04579824-132-13-19
    Average 90 stars, based on 1 article reviews
    web-based sequencing assay design tool design studio - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients"

    Article Title: Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients

    Journal: Oncology Letters

    doi: 10.3892/ol.2015.3600

    Targets for next generation sequencing assay, chromosomal location, length of the amplified regions and number of amplicons per target.
    Figure Legend Snippet: Targets for next generation sequencing assay, chromosomal location, length of the amplified regions and number of amplicons per target.

    Techniques Used: Next-Generation Sequencing, Amplification

    Comparison of Sanger sequencing, HRM and NGS methods used for mutation detection.
    Figure Legend Snippet: Comparison of Sanger sequencing, HRM and NGS methods used for mutation detection.

    Techniques Used: Comparison, Sequencing, Mutagenesis

    Difference graph, melting curves and sequencing chromatograms of the sensitivity test for the A746-E750del mutation in exon 19 of the epidermal growth factor receptor gene. Serial dilutions were performed in order to obtain a mutant to wild-type allele ratio of 12.5, 7.5 and 5%.
    Figure Legend Snippet: Difference graph, melting curves and sequencing chromatograms of the sensitivity test for the A746-E750del mutation in exon 19 of the epidermal growth factor receptor gene. Serial dilutions were performed in order to obtain a mutant to wild-type allele ratio of 12.5, 7.5 and 5%.

    Techniques Used: Sequencing, Mutagenesis

    Related Articles

    Sequencing:

    Article Title: Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients
    Article Snippet: A pool of custom upstream and downstream primers were designed using the web-based sequencing assay design tool Design Studio (Illumina, Inc.) ( http:designstudio.illumina.com/ ).

    Next-Generation Sequencing:

    Article Title: Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients
    Article Snippet: A pool of custom upstream and downstream primers were designed using the web-based sequencing assay design tool Design Studio (Illumina, Inc.) ( http:designstudio.illumina.com/ ).

    Amplification:

    Article Title: Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients
    Article Snippet: A pool of custom upstream and downstream primers were designed using the web-based sequencing assay design tool Design Studio (Illumina, Inc.) ( http:designstudio.illumina.com/ ).

    Comparison:

    Article Title: Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients
    Article Snippet: A pool of custom upstream and downstream primers were designed using the web-based sequencing assay design tool Design Studio (Illumina, Inc.) ( http:designstudio.illumina.com/ ).

    Mutagenesis:

    Article Title: Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients
    Article Snippet: A pool of custom upstream and downstream primers were designed using the web-based sequencing assay design tool Design Studio (Illumina, Inc.) ( http:designstudio.illumina.com/ ).



    Similar Products

    web-based sequencing assay design tool design studio  (Illumina Inc)
    90
    Illumina Inc web-based sequencing assay design tool design studio
    Targets for next generation <t> sequencing </t> assay, chromosomal location, length of the amplified regions and number of amplicons per target.
    Web Based Sequencing Assay Design Tool Design Studio, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/web-based+sequencing+assay+design+tool+design+studio/illumina+s+assay+design+tool/pmc04579824-132-13-19
    Average 90 stars, based on 1 article reviews
    web-based sequencing assay design tool design studio - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Targets for next generation sequencing assay, chromosomal location, length of the amplified regions and number of amplicons per target.

    Journal: Oncology Letters

    Article Title: Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients

    doi: 10.3892/ol.2015.3600

    Figure Lengend Snippet: Targets for next generation sequencing assay, chromosomal location, length of the amplified regions and number of amplicons per target.

    Article Snippet: A pool of custom upstream and downstream primers were designed using the web-based sequencing assay design tool Design Studio (Illumina, Inc.) ( http:designstudio.illumina.com/ ).

    Techniques: Next-Generation Sequencing, Amplification

    Comparison of Sanger sequencing, HRM and NGS methods used for mutation detection.

    Journal: Oncology Letters

    Article Title: Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients

    doi: 10.3892/ol.2015.3600

    Figure Lengend Snippet: Comparison of Sanger sequencing, HRM and NGS methods used for mutation detection.

    Article Snippet: A pool of custom upstream and downstream primers were designed using the web-based sequencing assay design tool Design Studio (Illumina, Inc.) ( http:designstudio.illumina.com/ ).

    Techniques: Comparison, Sequencing, Mutagenesis

    Difference graph, melting curves and sequencing chromatograms of the sensitivity test for the A746-E750del mutation in exon 19 of the epidermal growth factor receptor gene. Serial dilutions were performed in order to obtain a mutant to wild-type allele ratio of 12.5, 7.5 and 5%.

    Journal: Oncology Letters

    Article Title: Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients

    doi: 10.3892/ol.2015.3600

    Figure Lengend Snippet: Difference graph, melting curves and sequencing chromatograms of the sensitivity test for the A746-E750del mutation in exon 19 of the epidermal growth factor receptor gene. Serial dilutions were performed in order to obtain a mutant to wild-type allele ratio of 12.5, 7.5 and 5%.

    Article Snippet: A pool of custom upstream and downstream primers were designed using the web-based sequencing assay design tool Design Studio (Illumina, Inc.) ( http:designstudio.illumina.com/ ).

    Techniques: Sequencing, Mutagenesis